Sagimet Biosciences Inc.

General ticker "SGMT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $224.2M (TTM average)

Sagimet Biosciences Inc. does not follow the US Stock Market performance with the rate: -4.3%.

Estimated limits based on current volatility of 2.0%: low 6.28$, high 6.55$

Factors to consider:

  • Total employees count: 10 as of 2023
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.92$, 9.58$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.18$, 8.11$]

Financial Metrics affecting the SGMT estimates:

  • Negative: with PPE of -3.9 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 2.33 > -0.60
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Shareholder equity ratio, % of 95.62 > 64.29
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term SGMT quotes

Long-term SGMT plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $2.00MM $0.00MM $0.00MM
Operating Expenses $32.74MM $54.45MM $56.89MM
Operating Income $-30.74MM $-54.45MM $-56.89MM
Non-Operating Income $2.86MM $8.89MM $5.85MM
R&D Expense $19.78MM $38.44MM $39.05MM
Income(Loss) $-27.88MM $-45.57MM $-51.04MM
Net Income(Loss)* $-27.88MM $-45.57MM $-51.04MM
Stockholders Equity $91.06MM $155.81MM $111.38MM
Assets $96.72MM $160.26MM $116.48MM
Operating Cash Flow $-23.77MM $-42.44MM $-45.65MM
Investing Cash Flow $12.58MM $-61.68MM $4.56MM
Financing Cash Flow $86.17MM $104.82MM $0.28MM
Earnings Per Share** $-1.53 $-1.45 $-1.58

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.